Literature DB >> 1771684

A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment.

D W Smith1, V Balasubramanian, E Wiegeshaus.   

Abstract

The purpose of this study was to develop and evaluate a guinea pig model of experimental airborne tuberculosis for its ability to assess chemotherapeutic regimens for their efficacy against virulent tubercle bacilli in vivo during the initial phase of treatment. The tissues examined included primary lung lesions and the metastatic foci in lung and spleen which result from the naturally occurring bacillaemia. The treatments examined, INH + RIF, INH + EMB, EMB + RIF, were initiated 4 weeks after infection and were continued for 8 weeks. Although minor differences were observed in the time of onset of a significant bactericidal effect or in the rate of decline in the microbial population, all three treatment combinations resulted in a significant reduction in the number of M. tuberculosis H37Rv recovered from primary lung lesions, primary lesion-free lung lobes and spleen. X-rays taken of excised inflated lung lobes showed a relationship between the degree of calcification of primary lung lesions and the number of surviving bacilli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771684     DOI: 10.1016/0041-3879(91)90013-i

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  23 in total

1.  Growth characteristics of recent sputum isolates of Mycobacterium tuberculosis in guinea pigs infected by the respiratory route.

Authors:  V Balasubramanian; E H Wiegeshaus; D W Smith
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 2.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

Review 3.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

4.  Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Christine M Johnson; Rajesh Pandey; Sadhna Sharma; G K Khuller; Randall J Basaraba; Ian M Orme; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

6.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

7.  Aerosol infection model of tuberculosis in wistar rats.

Authors:  Sheshagiri Gaonkar; Sowmya Bharath; Naveen Kumar; V Balasubramanian; Radha K Shandil
Journal:  Int J Microbiol       Date:  2010-03-18

8.  Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach.

Authors:  Gavin J Ryan; Donald R Hoff; Emily R Driver; Martin I Voskuil; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Dean C Crick; John S Spencer; Anne J Lenaerts
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo.

Authors:  Nicole A Kruh; Jolynn Troudt; Angelo Izzo; Jessica Prenni; Karen M Dobos
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.

Authors:  Ramesh Jayaram; Radha K Shandil; Sheshagiri Gaonkar; Parvinder Kaur; B L Suresh; B N Mahesh; R Jayashree; Vrinda Nandi; Sowmya Bharath; E Kantharaj; V Balasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.